Navigation Links
diaDexus to Present at the RW Baird 2011 Health Care Conference
Date:9/1/2011

SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to present at Baird's 2011 Health Care Conference on Thursday, September 8, 2011 at 9:30 am Eastern Time (6:30 am Pacific Time) at the New York Palace Hotel in New York City, NY.  James Panek, Interim Chief Executive Officer, and Brian E. Ward, Interim Chief Operating Officer, will provide a corporate overview.  To access the live webcast and the subsequent archived recording of the presentation, please log onto diaDexus' website at www.diadexus.com/webcast.

About diaDexus, Inc.

diaDexus, Inc., based in South San Francisco, California, is focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease.  The company's PLAC ELISA Test for Lp-PLA2 is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. For more information, please visit the company's website at www.diaDexus.com


'/>"/>
SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. diaDexus Preannounces Strong Second Quarter Revenues
2. diaDexus, Inc. Reports 2011 First Quarter Financial Results
3. diaDexus Announces FDA Clearance for New Automated PLAC Test
4. diaDexus to Present at the Canaccord Genuity Healthcare Conference
5. diaDexus, Inc. Reports 2010 Third Quarter Financial Results
6. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
7. VaxGen and diaDexus Complete Merger
8. Cardium to Present at the Rodman & Renshaw Annual Healthcare Investment Conference
9. Watson to Present at the 2011 Bank of America Merrill Lynch Global Healthcare Conference
10. Volcano Corporation Announces Presentations at Upcoming Investor Conferences
11. Halozyme Therapeutics to Present at Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... -- Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe and ... painful intercourse and other painful pelvic pain conditions such as pelvic floor ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... July 5, 2017 Wolfmet 3D  printed tungsten collimator manufactured ... physics and manufacturing combine to progress molecular radiotherapy imaging. ... systems are unable to accurately quantify the radiation absorbed by ... regarding the success of this radiotherapy treatment has been available ... ...
Breaking Medicine Technology:
(Date:7/20/2017)... Los Angeles, California (PRWEB) , ... July 19, 2017 , ... ... which found that most successful weight loss surgery patients who had received a body ... Angeles Area health and beauty clinic Beverly Hills Physicians (BHP), which provides both types ...
(Date:7/20/2017)... ... July 20, 2017 , ... “Fidget”: a fun-filled, action-packed memoir ... public high school music and drama teacher who was a summa cum laude graduate ... a “Teacher of the Year” award. After her retirement from public school, Lynn continued ...
(Date:7/18/2017)... , ... July 18, 2017 , ... CannaKids, a California ... cannabis oils, announced today that at the WORLDZ Summit, taking place in Hollywood ... on the therapeutic benefits of medical cannabis for both pediatric and adult patients, and ...
(Date:7/18/2017)... VA (PRWEB) , ... July 18, 2017 , ... ... 11) , What Strategic Decisions Do You Need to Consider?, **An FDAnews ...      , 42 CFR Part 11, “Final Rule for Clinical Trials Registration ...
(Date:7/18/2017)... ... July 18, 2017 , ... ... basis, partners with the best medical professionals who offer the most effective and ... medical professional in their network, ensuring that each patient receives prompt and courteous ...
Breaking Medicine News(10 mins):